Nalmefene: quantitation of a new narcotic antagonist in human plasma using high performance-liquid chromatography with electrochemical detection.
A high performance-liquid chromatographic procedure employing electrochemical detection (LCEC) has been developed for the quantitation of a new narcotic antagonist, nalmefene, in human plasma. Following extraction of the plasma at pH9, the extract was chromatographed on a reverse-phase C18 column using naltrexone as an internal standard. An electrochemical detector equipped with a glassy carbon electrode monitored the elution of nalmefene and the internal standard. The method had a limit of sensitivity of 3 ng/ml of nalmefene using a 1 ml sample of plasma and the calibration curve was linear over a range of 3-200 ng/ml. The intra- and inter-assay coefficients of variation did not exceed 6 and 12% respectively over the entire range of the calibration curve. The LCEC method has been used to quantitate the plasma concentrations of nalmefene in man following oral administration of 64 mg of the drug. In one subject, a peak plasma concentration of 58 ng/ml occurred 2 hr after drug administration and declined to 5 ng/ml after 24 hr.
D002851:Chromatography, High Pressure Liquid / Q000295:instrumentation / Q000379:methods*; D004563:Electrochemistry; D006801:Humans; D007700:Kinetics; D009019:Morphinans / Q000097:blood*; D009270:Naloxone / Q000031:analogs & derivatives*; D009271:Naltrexone / Q000031:analogs & derivatives* / Q000097:blood; D009292:Narcotic Antagonists / Q000097:blood*; D013997:Time Factors
D009019:Morphinans; D009292:Narcotic Antagonists; D009270:Naloxone; D009271:Naltrexone; C038981:nalmefene